Moderna mRNA Flu Vaccine Wins FDA Advisory Committee Backing (2)

Moderna Inc.’s influenza vaccine made with mRNA technology was recommended for approval by outside advisers to the US Food and Drug Administration, a positive development for what has been a contentious product at the agency.

The vote is a major victory for Moderna, and represents a continuing turnabout at the FDA, which appears to be rapidly backing off controversial drug and vaccine decisions it made under previous leadership. Just yesterday, for example, the biotech UniQure NV said the agency would allow it to seek approval for its Huntington’s disease gene therapy this year, based on existing data. It’s ...